RxDoctor Payments Data

Allison Legler, MD

Dermatology · Santa Fe, NMNPI 1548437270

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 38.7% of the total.

$2,309in general payments, 2019–2025

Across 106 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$893
  • Johnson & Johnson$315
  • Incyte Corporation$305
  • Sanofi$237
  • Regeneron Healthcare Solutions, Inc.$154
  • Revance Therapeutics, Inc.$121
  • plus $284 from 10 others

What the payments were for

  • Food & beverage$2,19795%
  • Education$1125%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,309 in reported general payments places this provider in the 65th percentile of 52 dermatology providers in New Mexico.

See all dermatology providers in New Mexico

Medicare billing

Part B allowed, 2024
$236,592
Medicare patients
922
Services billed
4,742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil30$2,200
Clobetasol Propionate51$1,874
Doxycycline Hyclate52$907
Minoxidil51$837
ValacyclovirValacyclovir Hcl35$742
Betamethasone Valerate20$717
Triamcinolone Acetonide80$657
Dutasteride13$636
Fluocinonide20$450
Finasteride23$431
Betamethasone Dipropionate13$357
Ketoconazole12$197
Hydroxychloroquine Sulfate11$129
Hydrocortisone26$121

Paid to pharmacies, not to this prescriber.

Other dermatology in Santa Fe

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →